XLV vs TDNA
YTDYear to date
Level
Past year
Level
Fee
XLV winslower fee
Yield
XLV wins+1.3 pts
AUM
XLV4285.1× more
2–0XLV wins
XLV and TDNA · year-to-date · as of Nov 5, 2026 · AUM not scored
TDNA vs S&P 500
YTD$25.48 · +3.3% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return+3.3%+6.1%—————0.0%
Peer average+2.7%+8.5%+8.9%+24.4%+33.4%+84.3%+34.0%—
S&P 500 · VOO+1.6%−1.6%0.0%+13.4%+13.5%+91.7%+81.2%+831.3%
T. Rowe Price TDNA and Vanguard VOO · total return, dividends in · as of Nov 5, 2026
TDNA’s Holdings
TodayARGXArgenx Se5.2%KYMR4.7%KOD2.8%UTHR2.5%INSM2.4%VRTX2.3%NTRA2.3%MRNA2.3%RVMD2.3%BBIO2.1%PCVX2.1%SYRE2.0%PRAX1.9%DNTH1.8%ALKS1.8%CYTK1.8%MIRM1.7%RYTM1.7%TNGX1.6%CGON1.6%ARWR1.6%SRRK1.5%
ARGXArgenx Se5.2%KYMR4.7%KOD2.8%UTHR2.5%INSM2.4%VRTX2.3%NTRA2.3%MRNA2.3%RVMD2.3%BBIO2.1%PCVX2.1%SYRE2.0%
BiotechnologyMedical - DiagnosticsDrug Manufacturers - Specialty
T. Rowe Price TDNA · 0 holdings · tile size = share of the fund · as of Nov 4, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.3% | +24.0% | +24.0% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.3% | +23.3% | +23.3% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.3% | +30.6% | +30.6% | $10.6B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +23.7% | +23.7% | $4.9B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.1% | +23.4% | +23.4% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +71.5% | +71.5% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +29.8% | +29.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +27.1% | +27.1% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +26.0% | +26.0% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.6% | +36.8% | +36.8% | $1.2B | |
| 13 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +20.4% | +20.4% | $1.2B | |
| 14 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +26.8% | +26.8% | $1.2B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +26.9% | +26.9% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +38.2% | +38.2% | $538M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 5, 2026
TDNA Payouts by Year
TodayTDNA pays no distribution.
TDNA’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.3% | +3.1% | +24.0% | +33.5% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.3% | +3.1% | +23.3% | +32.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.3% | +2.7% | +30.6% | +45.4% | $10.6B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | +3.3% | +23.7% | +32.8% | $4.9B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.7B | |
| 6 | TDNA | T. Rowe Price Biotech ETFThis fund | 0.55% | — | +3.3% | new | new | $11.5M |
#28 cheapest of 39 · sorted by assetsOpen the Sectors table →
TDNA and its peer group · total return · as of Nov 5, 2026
Cards for This View
TDNA’s Top 10 Holdings
Today28.9%of TDNA sits in these 10
T. Rowe Price TDNA · weight in the fund · as of Nov 4, 2026
TDNA’s Holdings
TodayARGXArgenx Se5.2%KYMR4.7%KOD2.8%UTHR2.5%INSM2.4%VRTX2.3%NTRA2.3%MRNA2.3%RVMD2.3%BBIO2.1%PCVX2.1%SYRE2.0%PRAX1.9%DNTH1.8%ALKS1.8%CYTK1.8%MIRM1.7%RYTM1.7%TNGX1.6%CGON1.6%ARWR1.6%SRRK1.5%
ARGXArgenx Se5.2%KYMR4.7%KOD2.8%UTHR2.5%INSM2.4%VRTX2.3%NTRA2.3%MRNA2.3%RVMD2.3%BBIO2.1%PCVX2.1%SYRE2.0%
BiotechnologyMedical - DiagnosticsDrug Manufacturers - Specialty
T. Rowe Price TDNA · 0 holdings · tile size = share of the fund · as of Nov 4, 2026
TDNA vs Peer Average
YTDTDNAAvsBPeer average
1D+3.3%+2.7%
1M+6.1%+8.5%
3M[…]+8.9%
YTD[…]+24.4%
1Y[…]+33.4%
3Y[…]+84.3%
5Y[…]+34.0%
1–1level
38 Health care peers · each row scaled to its leader